Skip navigation
Speakers

Clarity, Guiding Strategies and Industry Benchmarking Amid Program Change and Policy Uncertainty

May 20-22, 2019
  • Orlando, FL

 

Gary Alexander
President and CEO, The Alexander Group;
former Head, Health and Human Services
Commonwealth of Pennsylvania and the State of Rhode Island

Marci Anderson
Auditor
VA Office of Inspector General, Office of Contract Review

Jeffrey Baab
Vice President, Life Sciences and Consulting
daVIZta

Mike Benedict
Vice President, Operations
Apexus

Steve Benz
Partner
Arnold & Porter

David Berger
Vice President, Legal Affairs
Hikma Pharmaceuticals USA Inc.

Joseph Birdsall
Senior Vice President, Financial Services
EVERSANA

Kathleen Black
Director, Government Strategy
Pfizer Inc

Brian Bohnenkamp
Partner
King & Spalding

Mike Borgia
Group Director, Government Channel
Johnson & Johnson

Larry Breen
Director, Financial Planning and Analysis
Sunovion Pharmaceuticals

Lynn Buhl
Director
KPMG LLP

JoAnn Bute
Director, Government Pricing and Compliance
Amneal Pharmaceuticals

David Chan
Co-Founder and CEO
Riparian

Jeffrey Clayton
Principal
Baker Tilly Virchow Krause, LLP

Lisa Clayton
Director, Government Reporting
Granard Pharmaceuticals

Chris Cobourn
Managing Director
KPMG LLP

Jonathan Connell
Senior Counsel
Bristol-Myers Squibb

Carmela Crimeni
Principal
Cumberland Consulting Group

Jennifer Crosswell
Manager, Government Pricing and Reimbursement
Arbor Pharmaceuticals

Meenakshi Datta
Partner
Sidley Austin LLP

Lenis De León
Senior Manager, Government Pricing and Compliance
Apotex

Rujul Desai
Of Counsel
Covington & Burling LLP

Rajeev Devgan
Director, Government Rebate Operations
Johnson & Johnson Health Care Systems Inc.

Susan Dunne
Managing Director
BDO

Aubrey Elmore
Engagement Manager
HighPoint Solutions, an IQVIA Company

Jennifer English
Senior Director, Market Access,
Pricing and Gross-to-Net Financial Operations
Insmed Incorporated

Sandy Fischer
Government Pricing Senior Director
Ingenus Pharmaceuticals, LLC

Simon Gisby
Managing Director
Deloitte Corporate Finance LLC

Tanuja Gohil
Associate Director, Government Contracts and Rebates
Novo Nordisk Inc.

Stacey Hale
Drug Rebate Manager
Oklahoma Health Care Authority

Josephine Hawkins
Associate Director, Medicaid
Astrazeneca

Doug Helling
Associate General Counsel
UCB

Kristin Hicks
Partner
Arnold & Porter

Christine Hinds
Policy Analyst
CMS

Glen Huttar
Director, Government Pricing
Johnson & Johnson Health Care Systems Inc.

Marcy Imada
Principal
Deloitte & Touche LLP

Murray Kay
former Senior VP and CFO, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

Stephanie Kupski
Director, Pricing and Contracts
Horizon Pharma

Mike Kurland
Vice President, Revenue Management & Compliance Solutions
EVERSANA

Michael Kvassay
Social Science Research Analyst,
Office of Evaluations and Inspections
OIG

Miree Lee, MS, MBA
Bio/Pharma Pricing Consultant
M. Lee Consulting, LLC

Lynn Lewis
Director, Data Acquisition and Integrity
IQVIA

Naomi Lopez-Bauman
Director, Healthcare Policy
Goldwater Institute

Jennifer Lospinoso
Managing Director
KPMG LLP

Josef Magpantay
Principal
Cumberland Consulting Group

Janice Matasi
Manager
KPMG LLP

Ed McAdam
Director, Government Pricing, Contract Operations and Analytics
Indivior Inc.

Jennifer Woodruff McElhenny
Manager
Baker Tilly Virchow Krause, LLP

Lisa McNair
Manager, Contracting, Pricing and Government Reporting
Indivior Inc.

Jesse Mendelsohn
Vice President, Centers of Excellence
Model N

Mark Myers
Director, Healthcare Resources Division
VA Office of Inspector General, Office of Contract Review

Mallory O’Connor
Director, Healthcare Policy and Federal Programs
BIO

Funso Olufade, PhD, MBA
Director, U.S. Commercial Finance
Amicus Therapeutics Inc.

Jill Page
Director, Government Pricing Strategy Analysis
Fresenius Medical Care

Andrew Parks
Director
KPMG LLP

Kathleen Peterson
Counsel
Hogan Lovells

Allison Pugsley
Partner
Hogan Lovells

Dorine Rascoe
Fiscal Program Manager, Drug Rebates
Maryland Department of Health

Ron Sandhu
Senior Manager, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

William Sarraille
Partner
Sidley Austin

Christopher Schott
Partner
Hogan Lovells

Phillip Scott
Senior Vice President, Business Development
NCPDP

John Shakow
Partner
King & Spalding

Brenna Sniderman
Senior Manager
Deloitte Services LP

James Stansel
Executive Vice President and General Counsel
PhRMA

David Tawes
Regional Inspector General,
Department of Health and Human Services
OIG

Nicholas Torre
Manager
Riparian

Stephanie Trunk
Partner
Arent Fox

Aaron Vandervelde
Managing Director
BRG

Raquel Villanueva
Senior Manager, Contract Operations
Jazz Pharmaceuticals

Debbie Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Trevor Wear
Partner
Sidley Austin LLP

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.

Constance Wilkinson
Member of the Firm
Epstein Becker Green

Greg Wiefel
Director
KPMG LLP

Cathy Zhang
Associate Director, Government Contracts
Eisai Inc.

Rick Zimmerer
Partner
KPMG LLP

 

Gary Alexander
President and CEO, The Alexander Group;
former Head, Health and Human Services
Commonwealth of Pennsylvania and the State of Rhode Island

Marci Anderson
Auditor
VA Office of Inspector General, Office of Contract Review

Jeffrey Baab
Vice President, Life Sciences and Consulting
daVIZta

Mike Benedict
Vice President, Operations
Apexus

Steve Benz
Partner
Arnold & Porter

David Berger
Vice President, Legal Affairs
Hikma Pharmaceuticals USA Inc.

Joseph Birdsall
Senior Vice President, Financial Services
EVERSANA

Kathleen Black
Director, Government Strategy
Pfizer Inc

Brian Bohnenkamp
Partner
King & Spalding

Mike Borgia
Group Director, Government Channel
Johnson & Johnson

Larry Breen
Director, Financial Planning and Analysis
Sunovion Pharmaceuticals

Lynn Buhl
Director
KPMG LLP

JoAnn Bute
Director, Government Pricing and Compliance
Amneal Pharmaceuticals

David Chan
Co-Founder and CEO
Riparian

Jeffrey Clayton
Principal
Baker Tilly Virchow Krause, LLP

Lisa Clayton
Director, Government Reporting
Granard Pharmaceuticals

Chris Cobourn
Managing Director
KPMG LLP

Jonathan Connell
Senior Counsel
Bristol-Myers Squibb

Carmela Crimeni
Principal
Cumberland Consulting Group

Jennifer Crosswell
Manager, Government Pricing and Reimbursement
Arbor Pharmaceuticals

Meenakshi Datta
Partner
Sidley Austin LLP

Lenis De León
Senior Manager, Government Pricing and Compliance
Apotex

Rujul Desai
Of Counsel
Covington & Burling LLP

Rajeev Devgan
Director, Government Rebate Operations
Johnson & Johnson Health Care Systems Inc.

Susan Dunne
Managing Director
BDO

Aubrey Elmore
Engagement Manager
HighPoint Solutions, an IQVIA Company

Jennifer English
Senior Director, Market Access,
Pricing and Gross-to-Net Financial Operations
Insmed Incorporated

Sandy Fischer
Government Pricing Senior Director
Ingenus Pharmaceuticals, LLC

Simon Gisby
Managing Director
Deloitte Corporate Finance LLC

Tanuja Gohil
Associate Director, Government Contracts and Rebates
Novo Nordisk Inc.

Stacey Hale
Drug Rebate Manager
Oklahoma Health Care Authority

Josephine Hawkins
Associate Director, Medicaid
Astrazeneca

Doug Helling
Associate General Counsel
UCB

Kristin Hicks
Partner
Arnold & Porter

Christine Hinds
Policy Analyst
CMS

Glen Huttar
Director, Government Pricing
Johnson & Johnson Health Care Systems Inc.

Marcy Imada
Principal
Deloitte & Touche LLP

Murray Kay
former Senior VP and CFO, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

Stephanie Kupski
Director, Pricing and Contracts
Horizon Pharma

Mike Kurland
Vice President, Revenue Management & Compliance Solutions
EVERSANA

Michael Kvassay
Social Science Research Analyst,
Office of Evaluations and Inspections
OIG

Miree Lee, MS, MBA
Bio/Pharma Pricing Consultant
M. Lee Consulting, LLC

Lynn Lewis
Director, Data Acquisition and Integrity
IQVIA

Naomi Lopez-Bauman
Director, Healthcare Policy
Goldwater Institute

Jennifer Lospinoso
Managing Director
KPMG LLP

Josef Magpantay
Principal
Cumberland Consulting Group

Janice Matasi
Manager
KPMG LLP

Ed McAdam
Director, Government Pricing, Contract Operations and Analytics
Indivior Inc.

Jennifer Woodruff McElhenny
Manager
Baker Tilly Virchow Krause, LLP

Lisa McNair
Manager, Contracting, Pricing and Government Reporting
Indivior Inc.

Jesse Mendelsohn
Vice President, Centers of Excellence
Model N

Mark Myers
Director, Healthcare Resources Division
VA Office of Inspector General, Office of Contract Review

Mallory O’Connor
Director, Healthcare Policy and Federal Programs
BIO

Funso Olufade, PhD, MBA
Director, U.S. Commercial Finance
Amicus Therapeutics Inc.

Jill Page
Director, Government Pricing Strategy Analysis
Fresenius Medical Care

Andrew Parks
Director
KPMG LLP

Kathleen Peterson
Counsel
Hogan Lovells

Allison Pugsley
Partner
Hogan Lovells

Dorine Rascoe
Fiscal Program Manager, Drug Rebates
Maryland Department of Health

Ron Sandhu
Senior Manager, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

William Sarraille
Partner
Sidley Austin

Christopher Schott
Partner
Hogan Lovells

Phillip Scott
Senior Vice President, Business Development
NCPDP

John Shakow
Partner
King & Spalding

Brenna Sniderman
Senior Manager
Deloitte Services LP

James Stansel
Executive Vice President and General Counsel
PhRMA

David Tawes
Regional Inspector General,
Department of Health and Human Services
OIG

Nicholas Torre
Manager
Riparian

Stephanie Trunk
Partner
Arent Fox

Aaron Vandervelde
Managing Director
BRG

Raquel Villanueva
Senior Manager, Contract Operations
Jazz Pharmaceuticals

Debbie Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Trevor Wear
Partner
Sidley Austin LLP

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.

Constance Wilkinson
Member of the Firm
Epstein Becker Green

Greg Wiefel
Director
KPMG LLP

Cathy Zhang
Associate Director, Government Contracts
Eisai Inc.

Rick Zimmerer
Partner
KPMG LLP